BIOMAT Database Logo BIOMAT Database Logo

Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp). 1994

T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Second Department of Internal Medicine, Yamanashi Medical College, Japan.

This study was performed to examine the effects of blockade of the renin-angiotensin system on the development of hypertension and renal damage in stroke-prone spontaneously hypertensive rats (SHR-sp), using a non-peptide angiotensin II receptor antagonist, CV-11974. We examined changes in blood pressure, urinary protein excretion, creatinine clearance and renal morphology in CV-11974-treated SHR-sp rats and compared these variables with those in non-treated SHR-sp and Wistar Kyoto (WKY) rats, as well as in hydralazine-treated SHR-sp rats. CV-11974 lowered systolic blood pressure in a manner similarly to hydralazine (CV-11974 204 +/- 3, hydralazine 200 +/- 3, non-treated SHR-sp 284 +/- 9, WKY 155 +/- 5 mmHg), but reduced urinary protein excretion more than hydralazine (p < 0.01). There were no significant differences in creatinine clearance among experimental groups. The glomerulosclerosis index was greater in non-treated and hydralazine-treated SHR-sp rats than in CV-11974 treated SHR-sp and WKY rats (p < 0.01). Hydralazine-treated SHR-sp rats had a lower glomerulosclerosis index than the non-treated SHR-sp rats (p < 0.01). No significant differences were found in glomerulosclerosis index between CV-11974-treated SHR-sp and WKY rats. Tubular atrophy, tubular casts and interstitial fibrosis were observed in non-treated SHR-sp rats and, occasionally, in hydralazine-treated SHR-sp rats, but not in CV-11974-treated SHR-sp rats or WKY rats. These results indicate that the angiotensin II receptor antagonist was superior to hydralazine as far as renal protection was concerned. This suggests that renal damage in SHR-sp rats is associated not only with hypertension but also with activation of the renin-angiotensin system.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial

Related Publications

T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
The effects of central administration of angiotensin II type-1 receptor antagonist, CV-11974, in nephrectomized spontaneously hypertensive rats.
April 1994, Clinical and experimental pharmacology & physiology,
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Renal effects of an angiotensin II antagonist in stroke-prone spontaneously hypertensive rat.
January 1997, Nephron,
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
July 2002, Hypertension (Dallas, Tex. : 1979),
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Regional hemodynamic effects of the AT1 receptor antagonist CV-11974 in conscious renal hypertensive rats.
December 1995, Hypertension (Dallas, Tex. : 1979),
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Hypotensive and prophylactic effects of angiotensin II subtype 1 receptor antagonist, irbesartan, in stroke-prone spontaneously hypertensive rats.
January 2004, Clinical and experimental hypertension (New York, N.Y. : 1993),
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Hypertensive effects on pregnancy in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP).
January 1981, International journal of biological research in pregnancy,
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Chronopharmacology of Angiotensin II-receptor Blockers in Stroke-Prone Spontaneously Hypertensive Rats.
January 2011, Journal of pharmacological sciences,
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Chronopharmacology of angiotensin II-receptor blockers in stroke-prone spontaneously hypertensive rats.
January 2011, Journal of pharmacological sciences,
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Angiotensin type 1 receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats.
August 1996, Clinical science (London, England : 1979),
T Nakamura, and H Honma, and Y Ikeda, and R Kuroyanagi, and H Takano, and J Obata, and T Sato, and H Kimura, and Y Yoshida, and K Tamura
Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats.
June 2004, Hypertension research : official journal of the Japanese Society of Hypertension,
Copied contents to your clipboard!